Showing results (101-110 of 298) with videos related to
Sort By:
Pageof 30
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|April 1, 2005
Cytotoxic capacity of hepatitis C virus (HCV)--specific lymphocytes after in vitro immunization with HCV-derived lipopeptidesBettina Langhans, Susann Schweitzer, Ingrid Braunschweiger, et al.Plos One|July 7, 2011
Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosisHenning W Zimmermann, Sebastian Seidler, Nikolaus Gassler, et al.The Journal of Infectious Diseases|January 25, 2011
Genetic variation in IL28B and treatment-induced clearance of hepatitis C virus in HIV-positive patients with acute and chronic hepatitis CJacob Nattermann, Martin Vogel, Hans Dieter Nischalke, et al.Journal of Medical Virology|February 18, 2011
Evidence for extensive genotypic diversity and recombination of GB virus C (GBV-C) in GermanyMarkus Neibecker, Carolynne Schwarze-Zander, Jürgen K Rockstroh, et al.Journal of Hepatology|October 26, 2002
Inducible nitric oxide synthase (iNOS) and endothelial nitric oxide synthase (eNOS) expression in fulminant hepatic failureLudger Leifeld, Magdalene Fielenbach, Franz-Ludwig Dumoulin, et al.Annals of Nutrition & Metabolism|July 23, 2008
Bolus ingestion but not regular consumption of native or dealcoholized red wine modulates selected immunological functions of leukocytes in healthy volunteersSabine Ellinger, Bianca M Arendt, Rolf Fimmers, et al.The Journal of Infectious Diseases|January 15, 2004
Hepatitis C virus-derived lipopeptides differentially induce epitope-specific immune responses in vitroBettina Langhans, Susann Schweitzer, Hans Dieter Nischalke, et al.Hepatology (Baltimore, Md.)|April 7, 2023
Identification and characterization of a hepatic IL-13-producing ILC3-like population potentially involved in liver fibrosisJan Raabe, Kim M Kaiser, Michael ToVinh, et al.Frontiers in Pharmacology|March 5, 2016
Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic FibrosisHans-Theo Schon, Matthias Bartneck, Erawan Borkham-Kamphorst, et al.Clinical Case Reports|September 10, 2021
Ruxolitinib for treatment of polycythemia vera and myelofibrosis in patients after liver transplantationLeona Dold, Philipp Lutz, Annkristin Heine, et al.Pageof 30